Board Meeting23 Jul 2026, 02:28 pm
Alivus Life Sciences Closes Trading Window for Q1 FY27 Results
AI Summary
Alivus Life Sciences Ltd has announced the closure of its trading window from July 1, 2026, to August 1, 2026, inclusive. This closure is in preparation for the board meeting scheduled for July 30, 2026, where the unaudited financial results for the quarter ended June 30, 2026, will be considered and approved. The company has informed its designated persons about this trading window restriction as per SEBI regulations.
Key Highlights
- Trading window closed from July 1 to August 1, 2026.
- Purpose is to approve unaudited financial results for Q1 FY27.
- Board meeting scheduled for July 30, 2026.
- Designated persons informed about the closure.
- Adheres to SEBI (Prohibition of Insider Trading) Regulations, 2015.
Price Impact
More from GLS